Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Turmeric + black cumin seed** is a combination product or polyherbal supplement containing extracts or oils from turmeric (*Curcuma longa*) rhizomes and black cumin (*Nigella sativa*) seeds. Both ingredients have been widely studied for anti-inflammatory, antioxidant, immune modulating, and metabolic health benefits. This combination is formulated to maximize efficacy, with some commercial supplements using proprietary forms for enhanced absorption, such as curcumin elite and concentrated black cumin seed oil. The mechanism of action involves synergistic effects: curcumin from turmeric inhibits NF-κB activation and scavenges free radicals, while thymoquinone from black cumin seed and other essential oil constituents act as anti-inflammatory, antioxidant, and cytotoxic agents via protein denaturation inhibition, free radical scavenging, and modulating targets related to ROS and cancer cell proliferation (such as NOX2, NF-κB, and mdm2)[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on turmeric + black cumin seed.